InvestorsHub Logo
Followers 794
Posts 30216
Boards Moderated 1
Alias Born 04/02/2009

Re: None

Wednesday, 12/02/2009 11:36:16 AM

Wednesday, December 02, 2009 11:36:16 AM

Post# of 56
OISI Ophthalmic Imaging Systems DD:

Ophthalmic Imaging Systems (www.oisi.com) is the leading provider of ophthalmic digital imaging systems. The Company designs, develops, manufactures and markets digital imaging systems, image management and integrated EMR/Practice Management solutions for the eye care market. With over twenty years in the ophthalmic imaging business, the Company has consistently introduced new, innovative technologies. Through OIS' wholly-owned subsidiary, Abraxas Medical Solutions, the company provides Electronic Medical Records and Practice Management software to Ophthalmology as well as OB/GYN, Orthopedic and Primary care. The Company markets and supports its products through an extensive network of dealers, distributors, and direct representatives.

************************************************************************
Share Structure as of Sept 30, 2009:
Authorized Shares: 35,000,000
Outstanding Shares: 26,500,059
Float: 16,761,831

Outstanding Shares as of November 30, 2009: 26,500,059

Major Holders Breakdown:
% of Shares Held by All Insider and 5% Owners: 36%
% of Shares Held by Institutional & Mutual Fund Owners: 5%
% of Float Held by Institutional & Mutual Fund Owners: 8%
Number of Institutions Holding Shares: 3

Insider Holders:
Holder/Shares/Reported
U.M. Accelmed, Ltd Partnership 9,633,228 June 24, 2009
Allon Gil 60,000 December 3, 2008
Shenhar Ariel 30,000 December 10, 2008
Phillips Jonathan R 15,000 May 23, 2008

Institutional Holders:
Holder/Shares.Reported
Perritt Capital Management, Inc. 710,000 September 30, 2009
Bard Associates Inc. 544,400 September 30, 2009
Blair (William) & Company, L. L. C. 15,500 September 30, 2009

Mutual Fund Holder:
Holder/Shares/Reported
Perritt Emerging Opportunities Fund 665,000 September 30, 2009

Investor Relations:
KCSA Strategic Communications
Todd Fromer 212-896-1215
Garth Russell 212-896-1250

************************************************************************
Contacts:
Gil Allon, CEO
(916) 646-2020

Ariel Shenhar, CFO
ashenhar@oisi.com
P: 800.338.8436
F: 916.646.0207

Ophthalmic Imaging Systems Inc
221 Lathrop Way
Suite I
Sacramento, CA 95815
P: +1916.6462020
F: +1916.6460207

************************************************************************
Financials from 10Q as of September 30, 2009:
Cash and cash equivalents $4,811,027
Total current assets 8,564,468
Total assets $10,886,902
Total current liabilities 3,960,308
Total liabilities 5,478,591
Sales, Three months ended September 30, $2,765,878
Net income (loss) $ 85,656
Net increase (decrease) in cash and equivalents 2,586,402
Cash and equivalents, beginning of the period 2,224,625
Cash and equivalents, end of the period $ 4,811,027

************************************************************************
Ophthalmic Imaging Systems Receives FDA Clearance to Market Revolutionary New Portable Digital Imaging Device http://investorshub.advfn.com/boards/read_msg.aspx?message_id=44032138

All News: http://ih.advfn.com/p.php?pid=news&cb=1259633917&symbol=OISI

All SEC Filings: http://www.sec.gov/cgi-bin/browse-edgar?company=Ophthalmic+Imaging&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

IHub Message Board: http://investorshub.advfn.com/boards/board.aspx?board_id=13727

Charts by MrGreenPenny: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=44039890

************************************************************************
Officers and Directors:
Name Age Since Current Position
Phillips, Jonathan 36 2007 Independent Director
Greer, William 42 2007 Independent Director
Maurincomme, Eric 42 2008 Independent Director
Inbar, Menachem 60 2009 Independent Director
Geiger, Uri 41 2009 Director
Shenhar, Ariel 43 2002 Chief Financial Officer, Vice President, Secretary, Director
Allon, Gil 47 2002 Chief Executive Officer, Director
Ram, Uri 60 2009 Chairman of the Board

Mr. Gil Allon is Chief Executive Officer, Director of Ophthalmic Imaging Systems. He is Board of Directors since August 2000 and has served as Chief Executive Officer since January 2002. Mr. Allon has acted in the capacity of Chief Executive Officer since August 2000. Mr. Allon is also a member of the Compensation, Option and Nominations Committees of Board of Directors. Mr. Allon served as the Vice President and chief Operating Officer of MediVision from June 1993 until August 2000. Mr. Allon also served as a member of the Board of Directors of MediVision since MediVision’s inception in June 1993 through December 2004. Mr. Allon received his B.A. and M.Sc. in Computer Science, both with distinction, from the Technion Israel Institute of Technology in Haifa, Israel in May 1987 and December 1989, respectively, and his M.B.A. with distinction in Business Management from the University of Haifa in September 1999.

Mr. Uri Ram is Chairman of the Board of Ophthalmic Imaging Systems since March 2009. He was recommended for the director position by Yigal Berman, a former director of board. He was appointed as an independent director and Chairman of Board in March 2009. Mr. Ram is the Chairman of the Audit Committee and a member of the Compensation, Option and Nominations Committees of Board. Currently, he serves as the Sr. Vice President and Chief Financial Officer of Gefen Inc. and is the CEO/Owner of Juram Ltd. and Irams Inc., management consulting companies that also invests in new startups. Since 1990, Mr. Ram has served as the President of Del-Ta Engineering & Equipment Ltd., a holding company with $30 million in sales and as the Senior VP of Inter-Gamma Investment Ltd. Inter-Gamma Investment Ltd. is a shareholder of MediVision Medical Imaging Ltd., parent company. Mr. Ram has a Master of Arts degree from Israel National Defense College, and a Bachelor of Economics and Political sciences from Bar Ilan University and participated in an EMBA program at the Tel Aviv University. Mr. Ram is a retired Brigadier General of the Israeli Air Force.

Mr. Ariel Shenhar is Chief Financial Officer, Vice President, Secretary, Director of Ophthalmic Imaging Systems. He is Directors since August 2000, has served as Vice President and Chief Financial Officer since July 2002 and has served as Secretary since August 2002. Mr. Shenhar also served as a member of the Board of Directors of MediVision from August 1994 through December 2004 and as its Vice President and Chief Financial Officer from January 1997 until May 2005. Mr. Shenhar served as a member of the Board of Directors of Fidelity Gold Real Estate Markets Ltd., an Israeli public company engaged in real estate, from 1994 to 1998, as an accountant at Nissan Caspi & Co. Certified Public Accountants in Jerusalem, Israel in 1996, and at Witkowski & Co. Certified Public Accountants in Tel Aviv, Israel from 1994 to 1995. Mr. Shenhar received his B.A. in Economics and Accounting in June 1992 and his M.B.A. in Finance, with distinction, in June 1999 both from the Hebrew University in Jerusalem, Israel, and has been a Certified Public Accountant since January 1997.

************************************************************************
Recent Developments:

Ophthalmic Imaging Systems (OIS) Receives FDA Clearance To Market Revolutionary New Portable Digital Imaging Device, Monday 30 Oct 09
Ophthalmic Imaging Systems (OIS) announced that its revolutionary new portable imaging device, the OIS EyeScan, has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA).

Ophthalmic Imaging Systems (OIS) to Launch OIS EyeScan and Other New Products at American Academy of Ophthalmology's, Thursday, 22 Oct 2009
Ophthalmic Imaging Systems (OIS) announced that it will launch two new products and improvements to the OIS EMR and OIS PM solutions at the American Academy of Ophthalmology's (AAO) 113th Annual Meeting, being held October 24 - 27, 2009, at the Moscone Convention Center in San Francisco, CA. The new products are: OIS EyeScan-The OIS EyeScan is a revolutionary new portable imaging device that is capable of imaging both the anterior and posterior segment of the eye and OIS Symphony Digital Reporter

Ophthalmic Imaging Systems (OIS) Announces Private Equity Financing, Monday, 29 Jun 2009
Ophthalmic Imaging Systems (OIS) announced it has signed a purchase agreement with U.M. AccelMed (AccelMed), Limited Partnership for a $6.0 million private placement of the Company`s common stock and warrants to be completed in two installments. Under the terms of the purchase agreement, OIS may issue up to an aggregate of 13,214,317 shares of its common stock and warrants to purchase up to an aggregate of 4,404,772 shares of its common stock. The Company intends to use the net proceeds for working capital and general corporate purposes. The first installment of $4.0 million was completed on June 24, 2009. In the first installment OIS sold 9,633,228 shares of common stock at a purchase price of $0.415 per share and issued three-year warrants to purchase up to 3,211,076 shares of common stock at $1.00 per share. The second installment of $2.0 million, consisting of 3,581,089 shares of common stock at a purchase price of $0.558 per share and warrants to purchase 1,193,696 shares of common stock at $1.00 per share, is expected to be completed by April 15, 2010.

Ophthalmic Imaging Systems (OIS) Announces Resignation Of Mr. Berman As Chairman-Form 8-K, Thursday, 19 Mar 2009
Ophthalmic Imaging Systems (OIS) announced in its Form 8-K that Yigal Berman has notified the Company of his resignation from the Company's Board of Directors (the Board) as a result of health issues, effective immediately. As of such date, Mr. Berman was the Chairman of the Board and Chairman of its Audit, Compensation, Option, and Nominations Committees of the Board. On March 18, 2009, the Board has appointed Mr. Ram as its Chairman as well as Chairman of the Audit Committee and as a member of the Compensation, Option and Nominations Committees.

Ophthalmic Imaging Systems (OIS) To Launch Seven New Products, Wednesday, 5 Nov 2008
Ophthalmic Imaging Systems (OIS) announced that it will launch seven new software solutions. The seven new products to be introduced will include OIS EMR, OIS PM, Symphony WebTM, Symphony Draw, Symphony Link, PerfectView and FAF Super-Resolution.

This post is in my opinion.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.